Global breast cancer brachytherapy market to be valued at $1.88b by 2035

It is expected to witness a 6.94% CAGR growth during the period.

The global breast cancer brachytherapy market is projected to reach $1.88b by 2035, at a compound annual growth rate (CAGR) of 6.94%, according to Research and Markets.

The sector’s expansion is attributed to factors such as the rising incidence of breast cancer, developments in brachytherapy techniques, and an increasing preference for less invasive treatment options.

In line with this, supportive government funding, initiatives aimed at cancer treatment, and the expansion of healthcare infrastructure in emerging markets are contributing to its growth.

In terms of technology, the high-dose-rate brachytherapy segment accounted for the highest revenue-grossing segment in the global market last year.

Meanwhile, the low-dose-rate brachytherapy segment is anticipated to grow at the fastest CAGR during the forecast period.